T. Zheng

发表

Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy.

Mariano J. Alvarez, K. Pienta, J. Eastham, 2014, Cancer cell.

Sensitization Effects of Repurposed Blood Pressure-regulating Drugs on Drug-resistant Cancer Cells

Sungpil Yoon, Hyung Sik Kim, T. Zheng, 2021, AntiCancer Research.

NKX3.1 Suppresses TMPRSS2-ERG Gene Rearrangement and Mediates Repair of Androgen Receptor-Induced DNA Damage.

E. Gelmann, C. Bowen, T. Zheng, 2015, Cancer research.

A Molecular Signature Predictive of Indolent Prostate Cancer

Andrea Califano, Pavel Sumazin, Mukesh Bansal, 2013, Science Translational Medicine.

Nkx3.1 controls the DNA repair response in the mouse prostate

E. Gelmann, Hailan Zhang, C. Chua, 2015, The Prostate.

ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.

N. Schultz, G. Iyer, H. Al-Ahmadie, 2017, Cancer research.

Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial

Prabhjot S. Mundi, H. Hibshoosh, M. Maurer, 2017, Clinical and Translational Oncology.

[Influence of serum storage on the laboratory results of prostate-specific antigen].

Xiao-Jun Li, T. Zheng, Ai-Li Wang, 2013, Zhonghua nan ke xue = National journal of andrology.

Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.

M. Loda, M. Rubin, H. Klocker, 2023, European urology.